Skip to content

Mipharma

Active Risk: not assessed
Private limited companyfounded 201510 yrs activeDriesknoklaan 25, 8540 Deerlijk, BelgiumKBO/BCE: BE 0638.985.223
Summary

Mipharma has a registered holding activity and consists mainly of financial fixed assets; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €267,638 and a net result of €39,091. Equity is growing by ~22.6% per year across the filed fiscal years. Its solvency ranks better than 30% of 10519 sector peers (fiscal year 2025). The company has been active since 2015 and the Belgian State Gazette contains no insolvency or warning signals.

Checked score

Outside the general model
Holding: general score not applicable
The company has a registered holding activity and financial fixed assets account for more than half of its assets. The general operating-company model is unsuitable for this profile, so we show no financial axes either. Filed figures remain available.
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

1 signal. The signal on the left, the evidence on the right.
○neutral
neutral · Latest accounts filed on time
The financial year that closed on 30-06-2025 was due by 31-01-2026 and was filed on 26-01-2026, 5 days ahead of the deadline.
NBB · 9 filings
Deviation from the deadline
2025
5 d early
2024
9 d early
2023
1 d early
2022
4 d early
2021
6 d early
2020
5 d early
2019
1 d early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 4 days before the deadline; the sector median for financial year 2024 is on the deadline day, and 46% of the sector filed late.

Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 30-06-2026 and is due by 31-01-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
30-06-2026 close28-09-2026 today31-01-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 29 September 2015, Mipharma was incorporated.1 Total assets went from EUR 1.3 million in 2019 to EUR 1.4 million in 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2019 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, abbreviated schema

Equity
€267,638▼ 18.5%
2024 · €328,547
Total assets
€1.4m▲ 1.7%
2024 · €1.3m
Net result
€39,091▼ 40.1%
2024 · €65,242
Working capital
-€181,123▼ 104%
2024 · -€88,673
Trend over the years

Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings. Dashed line: the median.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Operating result€96,427▼ 0.2%€99,067▲ 2.7%€87,573▼ 11.6%€91,323▲ 4.3%€58,049▼ 36.4%
Net result€69,096within the sector's middle half▲ 24.8%€61,155within the sector's middle half▼ 11.5%€61,797within the sector's middle half▲ 1.1%€65,242within the sector's middle half▲ 5.6%€39,091within the sector's middle half▼ 40.1%
Equity€180,353within the sector's middle half▲ 62.1%€241,508within the sector's middle half▲ 33.9%€303,305within the sector's middle half▲ 25.6%€328,547within the sector's middle half▲ 8.3%€267,638within the sector's middle half▼ 18.5%
Total assets€1.3mwithin the sector's middle half▼ 0.5%€1.3mwithin the sector's middle half▼ 0.5%€1.3mwithin the sector's middle half▼ 0.2%€1.3mwithin the sector's middle half▲ 1.7%€1.4mwithin the sector's middle half▲ 1.7%
Debt€1.2m▼ 6.1%€1.1m▼ 5.8%€1.0m▼ 6.0%€1.0m▼ 0.3%€1.1m▲ 8.2%
Working capital-€76,792below the sector's middle half▼ 3.4%-€77,446below the sector's middle half▼ 0.9%-€82,981below the sector's middle half▼ 7.1%-€88,673below the sector's middle half▼ 6.9%-€181,123below the sector's middle half▼ 104%
Solvency13.5%below the sector's middle half▲ 5.2pp18.2%within the sector's middle half▲ 4.7pp22.9%within the sector's middle half▲ 4.7pp24.4%within the sector's middle half▲ 1.5pp19.5%within the sector's middle half▼ 4.9pp
Current ratio0.23below the sector's middle half▼ 0.020.18below the sector's middle half▼ 0.050.14below the sector's middle half▼ 0.040.29below the sector's middle half▲ 0.150.24below the sector's middle half▼ 0.04
Return on assets (ROA)5.2%within the sector's middle half▲ 1.0pp4.6%within the sector's middle half▼ 0.6pp4.7%within the sector's middle half▲ 0.1pp4.8%within the sector's middle half▲ 0.2pp2.9%within the sector's middle half▼ 2.0pp
above within below the middle half (P25 to P75) of NACE 47, Retail trade, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
€0€25,000€50,000€75,000€100,000Operating result 2021: €96,427€96,427Net result 2021: €69,096€69,096Operating result 2022: €99,067€99,067Net result 2022: €61,155€61,155Operating result 2023: €87,573€87,573Net result 2023: €61,797€61,797Operating result 2024: €91,323€91,323Net result 2024: €65,242€65,242Operating result 2025: €58,049€58,049Net result 2025: €39,091€39,09120212022202320242025€0€25,000€50,000€75,000€100,000Operating result 2023: €87,573€87,600Net result 2023: €61,797€61,800Operating result 2024: €91,323€91,300Net result 2024: €65,242€65,200Operating result 2025: €58,049€58,000Net result 2025: €39,091€39,100202320242025
The operating result falls in 2025; 2025 is 36% below 2024 and is the lowest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.4m
Fixed assets €1.3m =
Current assets €58,470 ▲ 62.9%
Equity and liabilities €1.4m
Equity €267,638 ▼ 18.5%
Debt €1.1m ▲ 8.2%
Debt's share of the balance-sheet total rises from 75.6% to 80.5%. Equity is lower and debt is higher.
Key figures and ratios
2025 value · change against 2024
ROE
14.6%▼
2024 · 19.9%
Debt ≤ 1 year
€239,594▲
2024 · €124,565
Debt > 1 year
€858,910▼
2024 · €890,451
Income taxes
€9,304▼
2024 · €16,311
Staff costs
-€436
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 43 lines
Balance sheet Code20242025
Assets
Total assets20/58€1.3m€1.4m▲
Fixed assets21/28€1.3m€1.3m=
Financial fixed assets28€1.3m€1.3m=
Current assets29/58€35,892€58,470▲
Amounts receivable within one year40/41€31,961€46,930▲
Trade receivables40€22,180€23,960▲
Other amounts receivable41€9,781€22,970▲
Cash at bank and in hand54/58€3,296€10,906▲
Deferred charges and accrued income490/1€634€634=
Equity and liabilities
Total equity and liabilities10/49€1.3m€1.4m▲
Equity10/15€328,547€267,638▼
Contributions10/11€18,600€18,600=
Reserves13€1,860€1,860=
Distributable reserves133€1,860€1,860=
Profit (loss) carried forward14€308,087€247,178▼
Amounts payable17/49€1.0m€1.1m▲
Amounts payable after more than one year17€890,451€858,910▼
Financial debts170/4€786,074€695,189▼
Other amounts payable178/9€104,377€163,721▲
Amounts payable within one year42/48€124,565€239,594▲
Current portion of amounts payable after more than one year42€78,156€85,957▲
Trade debts44€821€1,757▲
Suppliers440/4€821€1,757▲
Taxes, remuneration and social security45€5,588€11,880▲
Taxes450/3€5,588€11,880▲
Other amounts payable47/48€40,000€140,000▲
Accrued charges and deferred income492/3€2,916€2,916=
Income statement Code20242025
Remuneration, social security and pensions62--€436
Other operating charges640/8€1,075€1,094▲
Gross operating margin9900€92,398€58,706▼
Operating profit (loss)9901€91,323€58,049▼
Financial income75/76B€0€29▲
Recurring financial income75€0€29▲
Financial charges65/66B€9,770€9,683▼
Recurring financial charges65€9,770€9,683▼
Profit (loss) for the period before taxes9903€81,553€48,395▼
Income taxes67/77€16,311€9,304▼
Profit (loss) for the period9904€65,242€39,091▼
Profit (loss) for the period to be appropriated9905€65,242€39,091▼
Appropriation of the result
Profit (loss) to be appropriated9906€348,087€347,178▼
Profit (loss) brought forward from the previous period14P€282,845€308,087▲
Profit to be distributed694/7€40,000€100,000▲
Return on contributions (dividend)694€40,000€100,000▲

The notes to these accounts (15 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Remuneration, social security and pensions62-€0---€436-
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€4,847€0----
Other operating charges640/8-€1,881€980€1,075€1,094▲ 1.7%
Gross operating margin9900€101,748€100,948€88,553€92,398€58,706▼ 36.5%
Operating profit (loss)9901€96,427€99,067€87,573€91,323€58,049▼ 36.4%
Financial income75/76B-€30€950€0€29-
Recurring financial income75€0€30€950€0€29-
Financial charges65/66B-€22,484€10,514€9,770€9,683▼ 0.9%
Recurring financial charges65€17,323€22,484€10,514€9,770€9,683▼ 0.9%
Profit (loss) for the period before taxes9903€79,105€76,613€78,009€81,553€48,395▼ 40.7%
Income taxes67/77€10,009€15,458€16,212€16,311€9,304▼ 43.0%
Profit (loss) for the period9904€69,096€61,155€61,797€65,242€39,091▼ 40.1%
Profit (loss) for the period to be appropriated9905€69,096€61,155€61,797€65,242€39,091▼ 40.1%
Line20212022202320242025Change
Assets
Total assets20/58€1.3m€1.3m€1.3m€1.3m€1.4m▲ 1.7%
Fixed assets21/28€1.3m€1.3m€1.3m€1.3m€1.3m=
Financial fixed assets28€1.3m€1.3m€1.3m€1.3m€1.3m=
Current assets29/58€23,073€16,886€13,819€35,892€58,470▲ 62.9%
Amounts receivable within one year40/41€3,364€11,624€4,200€31,961€46,930▲ 46.8%
Trade receivables40-€1,250€0€22,180€23,960▲ 8.0%
Other amounts receivable41-€10,374€4,200€9,781€22,970▲ 135%
Cash at bank and in hand54/58€19,709€5,262€9,619€3,296€10,906▲ 231%
Deferred charges and accrued income490/1---€634€634=
Equity and liabilities
Total equity and liabilities10/49€1.3m€1.3m€1.3m€1.3m€1.4m▲ 1.7%
Equity10/15€180,353€241,508€303,305€328,547€267,638▼ 18.5%
Contributions10/11-€18,600€18,600€18,600€18,600=
Reserves13€1,860€1,860€1,860€1,860€1,860=
Non-distributable reserves130/1-€1,860€1,860---
Reserves not available under the articles1311-€1,860€1,860---
Distributable reserves133---€1,860€1,860=
Profit (loss) carried forward14€159,893€221,048€282,845€308,087€247,178▼ 19.8%
Amounts payable17/49€1.2m€1.1m€1.0m€1.0m€1.1m▲ 8.2%
Amounts payable after more than one year17€1.1m€990,399€922,240€890,451€858,910▼ 3.5%
Financial debts170/4-€948,685€864,230€786,074€695,189▼ 11.6%
Other amounts payable178/9-€41,714€58,010€104,377€163,721▲ 56.9%
Amounts payable within one year42/48€99,865€94,332€96,801€124,565€239,594▲ 92.3%
Current portion of amounts payable after more than one year42-€83,688€84,455€78,156€85,957▲ 10.0%
Trade debts44€887€3,119€5,972€821€1,757▲ 114%
Suppliers440/4-€3,119€5,972€821€1,757▲ 114%
Taxes, remuneration and social security45-€7,525€6,374€5,588€11,880▲ 113%
Taxes450/3-€7,525€6,374€5,588€11,880▲ 113%
Other amounts payable47/48---€40,000€140,000▲ 250%
Accrued charges and deferred income492/3-€1,235€2,060€2,916€2,916=
Line20212022202320242025Change
Profit (loss) for the period9904€69,096€61,155€61,797€65,242€39,091▼ 40.1%
+ Depreciation and write-downs630€4,847€0----
Operating cash flow (approximation)€73,943€61,155€61,797€65,242€39,091▼ 40.1%
Investment in fixed assets (approximation)-€0€0€0€0-
Change in cash--€14,447€4,357-€6,323€7,610▲ 220%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-01-2027
2026
26-01
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
22-01
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
30-01
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
27-01
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
30-06
Financial Equity above €200,000Eq €241,508 ▲33.9%
4 profitable years in a row build equity to €241,508.
25-01
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
30-06
Financial Highest result since 2019net €69,096 ▲24.8%
Net result €69,096, the highest in the series.
30-06
Financial Equity above €150,000Eq €180,353 ▲62.1%
3 profitable years in a row build equity to €180,353.
26-01
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
30-06
Financial Equity above €100,000Eq €111,258 ▲99.1%
2 profitable years in a row build equity to €111,258.
30-01
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema
2018
07-12
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
2017
08-12
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts

We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Deerlijk · 1 establishment unit since 2015
seat establishment The establishment unit on the map
Ground area
3,357 m²
Building footprint
272 m²
Volume, LiDAR
1,336 m³
Parcel 34009A0380/00H000, Flanders · tallest building 21.3 m, ±2 floors. Linked by address, not a title deed.
3 companies at this address See who is registered here
1 establishment unit
Mipharma BVBA
Driesknoklaan 25, 8540 DeerlijkRetail sale of pharmaceutical products
since 20152.245.929.882
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
34009A0380/00H000 Flanders 3,357 m² 1 · 272 m² 21.3 m · 2 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Structure & network

Owners and holdings

1 holding

Owners 0

The accounts to 30-06-2025 list no shareholders, and no other source names one.

Holdings 1

According to the annual accounts to 30-06-2025 of Mipharma and those of the other companies, the acts in the Belgian Gazette and the LEI register. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not fill in these statements, or need not, is missing.

Connections & network

No current directors or connected companies found in the register.

Similar companies · same sector, comparable size

Of 5,220 companies in sector 47730 we hold annual accounts for 3,862. 3,526 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Identification & contact

Identification
Legal formPrivate limited company
Founded29-09-2015
Fiscal year end30-06
Activities, NACEBEL 2025
47730Retail sale of pharmaceutical products
64210Activities of holding companies
96999Other personal services
E-invoicing
Reachable via Peppol
Peppol ID 0208:0638985223
Also 9925:BE0638985223
Registered 03-12-2025

Register as of 28 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.